Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study. (2015)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(15)70017-7

PubMed Identifier: 25726502

Publication URI: http://europepmc.org/abstract/MED/25726502

Type: Journal Article/Review

Volume: 14

Parent Publication: The Lancet. Neurology

Issue: 4

ISSN: 1474-4422